Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Liabilities and Shareholders Equity: 2009-2025

Historic Liabilities and Shareholders Equity for Innoviva (INVA) over the last 17 years, with Sep 2025 value amounting to $1.4 billion.

  • Innoviva's Liabilities and Shareholders Equity rose 16.04% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 billion, marking a year-over-year increase of 7.06%. This contributed to the annual value of $1.3 billion for FY2024, which is 4.63% up from last year.
  • As of Q3 2025, Innoviva's Liabilities and Shareholders Equity stood at $1.4 billion, which was up 7.16% from $1.3 billion recorded in Q2 2025.
  • Innoviva's Liabilities and Shareholders Equity's 5-year high stood at $1.4 billion during Q3 2025, with a 5-year trough of $789.1 million in Q2 2021.
  • Moreover, its 3-year median value for Liabilities and Shareholders Equity was $1.2 billion (2023), whereas its average is $1.2 billion.
  • As far as peak fluctuations go, Innoviva's Liabilities and Shareholders Equity skyrocketed by 49.65% in 2022, and later declined by 10.51% in 2023.
  • Over the past 5 years, Innoviva's Liabilities and Shareholders Equity (Quarterly) stood at $926.4 million in 2021, then spiked by 32.93% to $1.2 billion in 2022, then increased by 0.98% to $1.2 billion in 2023, then grew by 4.63% to $1.3 billion in 2024, then increased by 16.04% to $1.4 billion in 2025.
  • Its Liabilities and Shareholders Equity was $1.4 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.3 billion in Q1 2025.